FDA inspection

Noramco, Inc.: FDA inspection ending May 2, 2008

FDA inspection 519517 · No Action Indicated (NAI) · Wilmington, DE

Key facts

Inspection ID 519517
Firm Noramco, Inc.
FEI number 2522445
Address 500 Swedes Landing Rd
City Wilmington
State DE
ZIP 19801-4417
Fiscal year 2008
Inspection end date May 2, 2008
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections